Overview
HealthWarehouse.com Q3 sales decline 7% due to slowing DTC sales and GLP-1 market shifts
Company reports Q3 net loss of $72,000 but positive cash flow achieved
Year-to-date sales increase 97% over prior year, reflecting strong growth
Outlook
HealthWarehouse.com optimistic about new product launches diversifying its catalog
Company focusing on direct-to-patient market opportunities
HealthWarehouse.com investing in technology for efficiency and scalability
Result Drivers
GLP-1 MARKET SHIFT - Decline in sales driven by reduced compounded GLP-1 prescription sales
DTC SALES DECLINE - Direct-to-consumer prescription sales fell, impacting overall revenue
CASH FLOW POSITIVE - Despite sales decline, company achieved positive cash flow and increased cash reserves
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | $8.4 mln |
Press Release: ID:nBwbJfykfa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)